Access. Intelligence. Excellence
Pharmaceutical Industry Field Roles Increasingly Utilizing iPads but Use has not Translated to Increased Effectiveness, Best Practices, LLC Study Finds
CHAPEL HILL, N.C., March 30, 2018 /PRNewswire/ -- iPads have become commonplace for field roles within the pharmaceutical industry.
But this shift - away from laptops and toward tablet technology - has not always translated into increased effectiveness for field roles such as Medical Science Liaisons or Health Outcomes Liaisons. Only a third of participants in a Best Practices, LLC study said they had seen slight or great improvement of KOL call quality since deploying iPads to MSLs; 57% said call quality has stayed the same.
However, the most common key performance indicator used by study participants to measure iPad effectiveness was the number of scientific presentations delivered. And by that measure, participants said they felt the iPad had improved MSL effectiveness: a majority of study participants (59%) said there had been an increase in the number of scientific presentations delivered since the deployment of iPads to MSLs, according to the study.
To help medical affairs leaders improve the effectiveness of their MSLs' utilization of iPads or tablets, Best Practices, LLC conducted a benchmarking study to identify best practices for iPad utilization by MSLs.
The 47-page report - Deploying the iPad or Android-Based Tablet to Medical Science Liaison Teams: Benchmarking Training and Effectiveness - is focused on valuable metrics surrounding iPad field usage as well as the utilization of CRM and CLM software for increased productivity. Leaders responsible for field medical roles such as MSLs can use this study to better evaluate their utilization of iPads and tactics for improving the effectiveness of MSL interactions with the tool.
Key topics addressed in this report include:
- Extent of Implementation
- Setting of Training
- Tablets Compliance with CRM Systems
- Concerns on Security
- Measuring Effectiveness
For this study, Best Practices, LLC engaged 22 leaders from 16 biopharmaceutical companies and two medical device and health care firm through a benchmarking survey.
To access the full report or to download a complimentary summary containing insights found in this report, click on the following link: http://www.best-in-class.com/rr1490.htm.
For related research, visit the Best Practices, LLC Web site at www.best-in-class.com/.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis.
ACCESS AND INTELLIGENCE FOR ACHIEVING WORLD-CLASS EXCELLENCE